Skip to main content
. Author manuscript; available in PMC: 2023 May 31.
Published in final edited form as: Ann Plast Surg. 2021 Apr 1;86(4):463–468. doi: 10.1097/SAP.0000000000002471

Table 3.

Encounter Subject Matter by Time Period

Subject Preoperative Period Postoperative Period Total
N (%) N (%) N (%)
Surgical Site
 Erythema 0 (0.0) 25 (9.2) 25 (7.6)
 Dressing 1 (1.9) 21 (7.7) 22 (6.7)
 Drain 0 (0.0) 20 (7.3) 20 (6.1)
 Edema 0 (0.0) 17 (6.2) 17 (5.2)
 Drainage 0 (0.0) 14 (5.1) 14 (4.3)
 Sutures 0 (0.0) 8 (2.9) 8 (2.4)
 Bleeding 0 (0.0) 7 (2.6) 7 (2.1)
 Bruising 0 (0.0) 5 (1.8) 5 (1.5)
 Wound Management 0 (0.0) 1 (0.4) 1 (0.3)
 Unspecified 0 (0.0) 4 (1.5) 4 (1.2)
Medications
 Opioids 0 (0.0) 10 (3.7) 10 (3.1)
 Home Meds 4 (7.4) 4 (1.5) 8 (2.4)
 Over the Counter 2 (3.7) 4 (1.5) 6 (1.8)
 Refills 0 (0.0) 4 (1.5) 4 (1.2)
 Pharmacy 0 (0.0) 1 (0.4) 1 (0.3)
 Unspecified 0 (0.0) 3 (1.1) 3 (0.9)
 Antibiotics 0 (0.0) 1 (0.4) 1 (0.3)
Postoperative Activity Restrictions 4 (7.4) 29 (10.6) 33 (10.1)
Drain Output 0 (0.0) 31 (11.4) 31 (9.5)
Scheduling 6 (11.1) 22 (8.1) 28 (8.6)
Symptoms
 Pain 0 (0.0) 19 (7.0) 19 (5.8)
 Dizziness 0 (0.0) 3 (1.1) 3 (0.9)
 Nausea 0 (0.0) 1 (0.4) 1 (0.3)
 Constipation 0 (0.0) 1 (0.4) 1 (0.3)
Procedure 20 (37.0) 2 (0.7) 22 (6.7)
Employment 6 (11.1) 10 (3.7) 16 (4.9)
Other Unrelated Medical Problems 5 (9.3) 5 (1.8) 10 (3.1)
Preoperative Clearance 5 (9.3) 0 (0.0) 5 (1.5)
Insurance 1 (1.9) 0 (0.0) 1 (0.3)
DVT/PE 0 (0.0) 1 (0.4) 1 (0.3)
Total 54 (100.0) 273 (100.0) 327 (100.0)